CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


This is an archived document. The links are no longer being updated.

1997 Surveillance Slides

MDR TB Cases
United States, 1993 - 1997

Slide 19: Map Showing the MDR TB Cases, United States, 1993 - 1997
Slide 19. During 1993 through 1997, 43 states and the District of Columbia reported at least one multidrug-resistant TB (MDR TB) case (i.e., resistance to at least isoniazid and rifampin, the two most important anti-TB drugs). MDR TB requires the use of second-line anti-TB drugs and a prolonged duration of therapy. Physicians with clinical expertise in the management of MDR TB should always be involved in the care of these patients. Contact investigations around MDR TB cases also require clinical experts to assist in management of infected contacts. All health departments must be prepared to meet the challenge of MDR TB. 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333